Conducted in collaboration with researchers from the UC Davis School of Veterinary Medicine, this is the first country-wide clinical trial to evaluate the safety, efficacy and potency of VetCell Therapeutics’ feline allogeneic MSC therapy for treating FCGS VetCell...
SANTA ANA, Calif., September 5, 2019–VetCell Therapeutics USA, a pet-focused cell therapy division of PrimeGen Global, Inc., announced today that the company will be presenting multiple presentations at the North American Veterinary Regenerative Medicine Association’s...
PRESS RELEASE FOR IMMEDIATE RELEASE VetCell Therapeutics and Western University Seek Allogeneic Stem Cell Treatment for Canine Atopic Dermatitis The two parties will collaboratively study the efficacy and safety of treating canine...
PrimeGen Biotech Creates VetCell Therapeutics Subsidiary – Prioritizes Deployment of Cell Therapies for Improving Quality of Life of Pets Living with Degenerative Diseases VetCell to Offer Advanced Therapies Utilizing Allogeneic and Autologous Stem Cells Derived...
